Validity of Meta-Analytical Estimates and Hazard Ratios Quantifying Survival Benefit of Immunochemotherapy in Low PD-L1-Expressing Esophageal Squamous Cell Carcinoma.
Guo YuNa ZhangAi-Jia GuanYu-Wei QiaoGuo-Fu LiPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)